Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility
Singapore
THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.
The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.
TRENDING NOW
Government to bring forward raising of retirement age, give employers more financial support to create flexi-load jobs
If Europe goes to war, the fallout will be felt in East Asia
Former minister Maliki Osman, Revolut chairman join Asia Gulf Holdings advisory board
Small nuclear reactors could boost the Asean Power Grid: GE Vernova executive